Development and validation of risk-stratified biopsy decision pathways incorporating MRI and PSA-derived indicators.
Saved in:
| Title: | Development and validation of risk-stratified biopsy decision pathways incorporating MRI and PSA-derived indicators. |
|---|---|
| Authors: | Jin P; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China., Wang X; Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou, China., Ding Z; Department of Radiology, The Second People's Hospital of Wuhu, Wuhu, China., Yang L; Department of Radiology, Hangzhou Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou, China., Xu C; Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China., Wang X; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China., Huang F; Department of Radiology, Pinghu Hospital of Traditional Chinese Medicine, Pinghu, China. |
| Source: | Annals of medicine [Ann Med] 2025 Dec; Vol. 57 (1), pp. 2446695. Date of Electronic Publication: 2025 Jan 01. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2060 (Electronic) Linking ISSN: 07853890 NLM ISO Abbreviation: Ann Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2060 |
|---|---|
| DOI: | 10.1080/07853890.2024.2446695 |
